Eli Lilly and

NYSE: LLY · Real-Time Price · USD
702.09
17.66 (2.58%)
At close: Aug 15, 2025, 3:59 PM
702.15
0.01%
After-hours: Aug 15, 2025, 04:15 PM EDT

Eli Lilly and Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.27B 2.82B 2.07B 3.82B
Short-Term Investments
154.8M 109.1M 144.8M 90.1M
Long-Term Investments
3.22B 3.05B 2.9B 3.21B
Other Long-Term Assets
5.72B 4.99B 4.34B 4.08B
Receivables
13.28B 11.34B 8.56B 8.13B
Inventory
7.59B 5.77B 4.31B 3.89B
Other Current Assets
111.4M 149.5M 7.3M n/a
Total Current Assets
32.74B 25.73B 18.03B 18.45B
Property-Plant & Equipment
17.1B 12.91B 10.14B 8.99B
Goodwill & Intangibles
11.94B 11.85B 11.28B 11.58B
Total Long-Term Assets
45.98B 38.28B 31.46B 30.35B
Total Assets
78.71B 64.01B 49.49B 48.81B
Account Payables
3.23B 2.6B 1.93B 1.67B
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
5.12B 6.9B 1.5B 1.54B
Other Current Liabilities
7.15B 16.14B 3.91B 3.84B
Total Current Liabilities
28.38B 27.29B 17.14B 15.05B
Long-Term Debt
28.53B 18.32B 14.74B 15.35B
Other Long-Term Liabilities
7.54B 7.53B 6.75B 7.52B
Total Long-Term Liabilities
36.07B 25.85B 21.58B 24.6B
Total Liabilities
64.44B 53.14B 38.71B 39.65B
Total Debt
33.64B 25.23B 16.24B 16.88B
Common Stock
592.4M 593.6M 594.1M 596.3M
Retained Earnings
13.54B 10.31B 10.04B 8.96B
Comprehensive Income
-4.32B -4.33B -3.84B -7.36B
Shareholders Equity
14.19B 10.77B 10.65B 8.98B
Total Investments
3.37B 3.16B 3.05B 3.3B